Charles Evan Ballantyne Insider Profile
4 Followers
Charles Evan Ballantyne, Chief Financial Officer at Gain Therapeutics, holds ― shares in Gain Therapeutics (Ticker: GANX), holds 10.00K shares in Agenus (Ticker: AGEN), holds 10.00K shares in Theriva Biologics (Ticker: TOVX).
Charles Evan Ballantyne's Trading History
You May Also Like
Charles Evan Ballantyne insider profile FAQ
What is the percentage of profitable transactions made by Charles Evan Ballantyne?
The percentage of profitable transactions made by Charles Evan Ballantyne is 100%.
What is the average return per transaction made by Charles Evan Ballantyne?
The average return per transaction made by Charles Evan Ballantyne is 49.60%.
What stocks does Charles Evan Ballantyne hold?
Charles Evan Ballantyne holds: GANX, AGEN, TOVX stocks.
What was Charles Evan Ballantyne's most profitable transaction?
Charles Evan Ballantyne’s most profitable transaction was an Informative Buy of AGEN stock on September 29, 2015. The return on the trade was 55.00%.
What is Charles Evan Ballantyne's role in Gain Therapeutics?
Charles Evan Ballantyne's role in Gain Therapeutics is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
